HOOKIPA Pharma Inc.

(HOOK) Trade

By |

Profile

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Contact Information

Website: www.hookipapharma.com
Main Phone: +1 431 890-6360
Address: 350 Fifth Avenue
Address 2: 72nd Floor, Suite 7240
State: NY
City / Town: New York
Country: US
Postal Code: 10118

Issuer Information

Exchange: NGS
CEO: Joern Aldag
Employees: 104
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Contact Information

Website: www.hookipapharma.com
Main Phone: +1 431 890-6360
Address: 350 Fifth Avenue
Address 2: 72nd Floor, Suite 7240
State: NY
City / Town: New York
Country: US
Postal Code: 10118

Issuer Information

Exchange: NGS
CEO: Joern Aldag
Employees: 104
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 10.92 $ -0.3201 (-2.85%)
Last Price 10.92 Change $ -0.3201 Change % -2.85 Tick N/A
Bid 10.80 Bid Size 800.00 Ask 10.96 Ask Size 300.00
Open 11.24 High 11.25 Low 10.85 Prev Close 11.24
Last Trade Volume 10,499 52 Wk Hi 14.37 52 Wk Low 5.81
Market Cap 280.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 25,670,540.00 EPS (TTM) -1.51 PE Ratio -7.40 Exchange NGS